Copart CPRT Balance Sheet Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $3.35B-34.3% | $5.1B-2.5% | $5.23B+88.2% | $2.78B+17.5% | $2.37B-29.1% | ||
| $794.47M-7.8% | $861.63M+13.4% | $759.69M-0.4% | $762.81M-1.0% | $770.59M-14.0% | ||
| $49.63M+18.5% | $41.87M+3.6% | $40.41M+1.9% | $39.66M-10.9% | $44.51M-24.7% | ||
| $5.22B-15.5% | $6.18B-0.4% | $6.2B+7.8% | $5.75B+7.4% | $5.36B+7.9% | ||
| $3.72B+0.6% | $3.69B+1.2% | $3.65B+1.5% | $3.6B+0.8% | $3.57B+3.1% | ||
| $522.7M-0.1% | $523.47M+0.9% | $518.76M+0.2% | $517.78M-0.2% | $518.6M+1.8% | ||
| $53.94M-5.8% | $57.29M-3.9% | $59.62M-5.1% | $62.83M-5.4% | $66.42M-2.4% | ||
| $9.65B-8.9% | $10.59B+0.1% | $10.58B+4.9% | $10.09B+4.3% | $9.67B+5.3% | ||
| $598.29M+8.9% | $549.17M-9.6% | $607.39M+2.6% | $591.83M+2.6% | $576.92M+2.6% | ||
| $33.49M+6.7% | $31.38M+3.0% | $30.47M+0.1% | $30.44M+0.5% | $30.29M+12.6% | ||
| $685.26M+11.6% | $613.87M-21.4% | $781.2M+14.3% | $683.28M+4.0% | $657.13M+4.4% | ||
| $857.59M+8.9% | $787.73M-18.1% | $961.9M+8.9% | $883.41M+1.6% | $869.53M+0.7% | ||
| 1.6B0.0% | 1.6B0.0% | 1.6B0.0% | 1.6B0.0% | 1.6B0.0% | ||
| $7.65B-11.3% | $8.63B+1.6% | $8.5B+5.0% | $8.09B+5.1% | $7.7B+5.6% | ||
| $8.77B-10.4% | $9.79B+2.0% | $9.6B+4.5% | $9.19B+4.6% | $8.78B+5.8% | ||
| $9.65B-8.9% | $10.59B+0.1% | $10.58B+4.9% | $10.09B+4.3% | $9.67B+5.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Copart's total assets?
- Copart (CPRT) holds $9.6B in total assets, down 0.2% year over year.
- How much cash does Copart have?
- Copart holds $3.4B in cash and equivalents.
- Can Copart cover its short-term obligations?
- Its current ratio is 7.61 — current assets exceed current liabilities.
- Where does Copart's balance sheet data come from?
- Every line is extracted from Copart's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
